Who owns Pieris Pharmaceuticals?
- Ticker: PIRS
- CUSIP Number: 720795103
Tip: Access positions for across all investors
Analyze quarterly positions in Pieris Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pieris Pharmaceuticals stock
Who bought or sold Pieris Pharmaceuticals this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BVF | 21M | $3.8M | 0% | Dec 2023 |
|
| Lynx1 Capital Management | 9.8M | $1.8M | 0% | Dec 2023 |
|
| Citadel Advisors | 1.3M | $229k | 108% | Dec 2023 |
|
| Vanguard Group | 907k | $165k | -12% | Dec 2023 |
|
| CM Management | 750k | $137k | 15% | Dec 2023 |
|
| Millennium Management | 167k | $30k | -26% | Dec 2023 |
|
| Summit Trail Advisors | 140k | $26k | 100% | Mar 2024 |
|
| Virtu Financial | 90k | $16k | 100% | Dec 2023 |
|
| Citigroup | 89k | $16k | 0% | Dec 2023 |
|
| Two Sigma Investments | 41k | $7.4k | -3% | Dec 2023 |
|
| Bank of New York Mellon | 40k | $7.3k | 0% | Dec 2023 |
|
| NorthStar Asset Management | 39k | $7.1k | 100% | Dec 2023 |
|
| Two Sigma Advisers | 35k | $6.3k | 42% | Dec 2023 |
|
| Raymond James & Associates | 30k | $5.5k | 0% | Mar 2024 |
|
| NJ State Employees Deferred Compensation Plan | 30k | $5.5k | 0% | Dec 2023 |
|
| Goldman Sachs Group | 23k | $4.1k | 0% | Dec 2023 |
|
| Baader Bank | 20k | $2.7k | 100% | Dec 2023 |
|
| Commerce Bank N A | 20k | $3.6k | 0% | Dec 2023 |
|
| Kestra Advisory Services | 18k | $3.2k | 100% | Dec 2023 |
|
| Two Sigma Securities | 15k | $2.8k | -15% | Dec 2023 |
|
| Hudson Valley Investment Advisors | 14k | $2.6k | 0% | Mar 2024 |
|
| HPM Partners | 10k | $1.9k | 100% | Dec 2023 |
|
| Us Bancorp | 10k | $1.9k | 0% | Dec 2023 |
|
| UBS Group | 6.3k | $1.1k | -86% | Dec 2023 |
|
| Barclays | 5.0k | $1.0k | 0% | Dec 2023 |
|
| Wells Fargo & Company | 4.8k | $866.502000 | -17% | Dec 2023 |
|
| Cutler | 4.5k | $0 | 0% | Mar 2024 |
|
| 1620 Investment Advisors | 4.4k | $318k | 100% | Dec 2023 |
|
| Jpmorgan Chase & Co | 2.0k | $358.327800 | -98% | Dec 2023 |
|
| Rhumbline Advisers | 1.9k | $339.052200 | 0% | Dec 2023 |
|
| Royal Bank of Canada | 572.00 | $0 | -82% | Dec 2023 |
|
| Advisor Group Holdings | 516.00 | $94.015200 | 0% | Dec 2023 |
|
| Hanson McClain Advisors | 350.00 | $64.015000 | 0% | Dec 2023 |
|
| Bank of America Corporation | 145.00 | $25.998500 | 0% | Dec 2023 |
|
Who sold out of Pieris Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Aquilo Capital Management | Sep 2023 | 3.3M | $984k |
| Hrt Financial | Sep 2023 | 18k | $5.0k |
| National Asset Management | Sep 2023 | 17k | $5.1k |
| Tower View Investment Management & Research | Sep 2023 | 1.0k | $0 |